[ Home ]

Phospholipid Spectrum Disorders in Psychiatry and Neurology
Second Edition
Edited by Malcolm Peet, Iain Glen and David Horrobin

The first edition of this book signalled a fundamental change of direction in the way in which psychiatric and neurological dysfunctions were conceptualized and treated. Appearing in the last year of the last century, it heralded the kind of reorientation of thought that would be needed in the next if the problems besetting these two major areas of medicine were to be dealt with effectively. It would be hard to overestimate the impact produced by the first edition in the four years following its publication. It was instrumental in promoting widespread acceptance of the idea that major conditions such as schizophrenia, mania, depression, dyslexia, dyspraxia, Alzheimer's disease, and many disorders of movement, could all be considered as expressions of underlying faults in membrane phospholipid metabolism. In addition, it shifted emphasis away from an increasingly sterile search for abnormalities in the release, reuptake and receptor interactions of neurotransmitters, and towards what has proved to be the richly fertile ground of membrane phospholipid biochemistry.

Over the ensuing four years, research on the role of phospholipids in psychiatric and neurological conditions has expanded to a truly astonishing degree, giving rise to a flood of high-quality reports in major, peer-reviewed, scientific journals. International conferences on neuropsychiatric illnesses are now deemed incomplete if they do not include at least one session devoted to the latest work on phospholipids and on related theoretical developments. The growth of interest and research in the area of membrane phospholipids is reflected in the fact that the second edition of this major treatise is almost twice the length of the first, with a total of 80 authors contributing to 52 chapters.

The authors and editors of the second edition effectively convey the vigour and excitement of this new approach, which has not only helped to remove the stigma associated with labels such as schizophrenia and dyslexia, but which offers hope for the diagnosis, treatment and prevention of illnesses long thought to be only poorly – if at all – responsive to medical treatment.

A major blow was dealt to modern medical research by the untimely death of Dr David Horrobin, one of the editors of this book. He had emerged as the most important and influential figure in the promotion and development of research on membrane phospholipids. The second edition of Phospholipid Spectrum Disorders in Psychiatry and Neurology stands as an impressive monument to the infectious enthusiasm that he showed for his work and to his energy as research worker and writer; it is a fitting tribute to his intellectual and scientific integrity. In the introductory chapter, he sets the scene for the chapters that follow, as well as outlining the general context in which future developments may be expected in diagnostic and therapeutic techniques; in the final two chapters, he demonstrates his breadth of vision by setting phospholipid hypotheses into the dual contexts of the human genome – the epitome of modern biomedical science – and the evolutionary history of the human species. The authors of all chapters are recognized international experts and major authorities in their own areas of research and medical practice.

Sample pages from the Second Edition


Phospholipid Spectrum Disorders in Psychiatry and Neurology is essential reading for all those concerned with psychiatric and neurological disorders in their manifold forms, whether from the standpoint of clinical practice or of fundamental research – psychiatrists, neuroscientists, neurologists, psychologists, biochemists, pharmacologists, and indeed all those with a desire to understand the mechanisms linking many medical conditions which have for so long been regarded as separate and distinct.

Phospholipid Spectrum Disorder in Psychiatry and Neurology
Second Edition

ISBN: 1-871622-25-5
Carnforth: Marius Press (2003)
Edited by Malcolm Peet, Iain Glen and David Horrobin.
654 + xviii pp. 52 chapters. Hardback. Illustrated

Price: GB£140.26 / Euros 245.50 / US$258.00
Postage: (UK) £8.50; (Overseas) GB£ 12.00 / Euros 21.00 / US$ 22.00

Order this book...
 

View the contents of this book...

[ Back to top ]



Reviews in Contemporary Pharmacotherapy

RICP is an independent reviews journal.
Each issue is devoted to a single pharmaceutical agent or class of such agents.

The aim of the journal is to bring to clinicians, pharmacists, research workers, care agencies, and others with interests in the field of pharmacotherapy, up-to-date and critical surveys of work in some important aspect of applied pharmacology.

The journal publishes high-quality, authoritative review articles, by authors who are acknowledged experts in their respective fields of research or clinical practice.


List of Issue Titles:

Volume and Year Number Title

Vol. 13, 2004 1 Levetiracetam

Vol. 12, 2003 6
5
3&4
1&2
Clopidogrel
Tiagabine
Gabapentin in Neuropathic Pain
Pramipexole

Vol 11, 2000 5
3&4
2
1
Reboxetine
Chlamydia trachomatis and Azithromycin
Zolmitriptan
Tolterodine

Vol. 10, 1999 4
3
2
1
Origins of Lithium Therapy
Topiramate
Citalopram in Anxiety Disorders
Photodynamic Therapy

Vol. 9, 1998 8
7
6
5
4
3
2
1
Fluticasone
Moxonidine
Saruplase
Venlafaxine
Etidronate in Osteoporosis
Pamidronate disodium
Zopiclone
Quinagolide

Vol. 8, 1997 5
4
3
2
1
Terbinafine
Riluzole
Aceclofenac
Carbamazepine: A Reappraisal
Bisoprolol

Vol. 7, 1996 7
6
5
4
3
2
1
Tacrine
Sulpiride
Gabapentin
Fluvastatin
Ceftibuten
Anti-herpesvirus Agents
Ramipril

Vol. 6, 1995 11
10
9
8
7
6
5
4
3
2
1
Divalproex in Psychiatry
Tramadol
Vigabatrin
Ceftriaxone
Tacrine
Citalopram
Moricizine/Moracizine
Clozapine
Rifabutin
Fosfomycin Trometamol
Lacidopine

Vol. 5. 1994 6
5
4
3
2
1
Terazocin
Azithromycin
Sumatriptan
Oxybutynin Hydrochloride
Lamotrigine
Moclobemide

Vol. 4, 1993 7
6
5
4
3
2
1
Azeleic Acid
Sunscreens
Lithium: New Applications
Nicorandil
Felbinac
Lisinopril
Fosinopril

Vol. 3, 1992 9
8
7
6
5
4
3
2
1
Benzodiazepines and Driving
Famotidine
Calcipotriol
Clindamycin
Acemetacin
Oxytropium Bromide
Ciprofloxacin
Selegiline
Doxazosin

Vol. 2, 1991 3
2
1
Nicardipine
Dexfenfluramine
Lithium Augmentation Therapy

Vol. 1, 1990 3
2
1
Carbamazepine
Fluoxetine
Gammalinolenic Acid


Reviews in Contemporary Pharmacotherapy


ISSN: 0954-8602
Carnforth: Marius Press

Price per issue: GB£ 72.50 / Euros 126.50 / US$ 133.50
Postage: (UK) £2.00; (Overseas) GB£ 4.50 / Euros 8.00 / US$ 8.00

Order this item...

[ Back to top ]


Marius Press
Box 15, Carnforth, Lancashire LA6 1HU, UK
Tel: +44-(0)1524-733027   Fax: +44-(0)1524-736659
E-mail: books@mariuspress.com